Condition: Hip Surgery · Sponsor: FH ORTHO
The objective of this observatory is to generate additional real life clinical data in accordance with local regulation (i.e. Post-Market Clinical Follow-up (PMCF) study, a study carried out following the European Conformity (CE) marking of a device and intended to answer specific questions relating to clinical safety or performance (i.e. residual risks) of a device when used in accordance with its approved labelling). The difficulty of such an observatory is to be able to collect data on the different versions of the devices, on the different possible combinations of implants of an arthroplasty. The observatory must also be able to cover devices used in surgery to repair osteoarticular trauma. The observatory will be based on the principle of a "dynamic" cohort during the inclusion period, i.e. with possible inclusions to replace the premature exits. Technical solutions will be implemented to facilitate data collection from surgeons (electronic Case Report Form (eCRF) and from patients (Electronic Patient Reported Outcome (ePRO) on phone/tablet/computer).
This description comes directly from the study's public registry record.
Vincent GAUDIOT, MD · +33 2 40 95 92 81 · vincent.gaudiot@wanadoo.fr
Always discuss trial participation with your own doctor first.
| Clinique Pasteur | Guilherand-Granges, France | Recruiting |
| Centre Hospitalier Du Haut Bugey | Oyonnax, France | Recruiting |
| Polyclinique Reims-Courlancy | Reims, France | Recruiting |
| Clinique Mutualiste La Sagesse | Rennes, France | Recruiting |
| Clinique de l'Atlantique | Saint-Herblain, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05966220